REGULATION OF TGF-β ACTIVITY FOR ATTENUATION OF GLOMERULAR LESIONS
REGULATION OF TGF-β ACTIVITY FOR ATTENUATION OF GLOMERULAR LESIONS
批准号:
10470219
负责人:
OKUDA Seiya
金额:
$4.03万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999
中文摘要
The extracellular domain of TGF-β type 2 receptor can bind active TGF-β tightly but does not involvesignal transduction of TGF-β。Therefore,a large amount of TGF-β soluble receptor can prevent TGF-β binding to true TGF-β receptor. toinvestigate the effects of TGF-β soluble receptor on TGF-β action in vivo,the gene of TGF-β type 2 receptor extracellular domain was transfected into the muscle of rats byusing 5x10 - D18 - D1 recombinant adenovirus vector at 1 days before the unilateral uretalELISA assay. The Serum obstruction. Serum concentration of TGF-β soluble receptor was quantitatedconcentration of the soluble receptor at 10 days after the transfection was 70ng/ml,which was 50-fold higher than reported concentration of active form TGF-β in rats serum andconsidered to be sufficient to block the active TGF-β in体内。Tubular damage and interstitialfibrosis marked in ureteral obstruction rat kidney.这些课程由attenuated by theelevated level of the TGF-β soluble receptor. Interstitial fibronectin accumulation,vimentin表达式和macrophage accumulation were markedly decreased by TGF-β soluble receptorgene transfection. TGF-β type 2 soluble receptor is a potent inhibitor of TGF-βto modulate renalfibrosis。
英文摘要
The extracellular domain of TGF-β type 2 receptor can bind active TGF-β tightly but does not involve signal transduction of TGF-β. Therefore, a large amount of TGF-β soluble receptor can prevent TGF-β binding to true TGF-β receptor. To investigate the effects of TGF-β soluble receptor on TGF-β action in vivo, the gene of TGF-β type 2 receptor extracellular domain was transfected into the muscle of rats by using 5x10ィイD18ィエD1 recombinant adenovirus vector at 1 days before the unilateral uretal obstruction. Serum concentration of TGF-β soluble receptor was quantitated by ELISA assay. The serum concentration of the soluble receptor at 10 days after the transfection was 70ng/ml, which was 50-fold higher than reported concentration of active form TGF-β in rats serum and considered to be sufficient to block the active TGF-β in vivo. Tubular damage and interstitial fibrosis were marked in ureteral obstruction rat kidney. These lesions were attenuated by the elevated level of the TGF-β soluble receptor. Interstitial fibronectin accumulation, vimentin expression and macrophage accumulation were markedly decreased by TGF-β soluble receptor gene transfection. TGF-β type 2 soluble receptor is a potent inhibitor of TGF-βto modulate renal fibrosis.
期刊论文(29)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Ueda S: "Tetrahydrobiopterin restores endothelial function in chronic smokers"J Am Coll Cardiol. 35. 71-75 (2000)
Ueda S:“四氢生物蝶呤可恢复慢性吸烟者的内皮功能”J Am Coll Cardiol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Usui M, Matsuoka H, Miyazaki H et al.: "Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure."Life Science. 62. 2425-2430 (1998)
Usui M、Matsuoka H、Miyazaki H 等人:“充血性心力衰竭患者内源性一氧化氮合酶抑制剂增加。”生命科学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Miyazaki H, Matsuoka H, Usui M et al.: "Endogenous nitric oxide sythase inhibitor, a novel marker of atherosclerosis."Circulation. 99. 1141-1146 (1999)
Miyazaki H、Matsuoka H、Usui M 等人:“内源性一氧化氮合酶抑制剂,动脉粥样硬化的新标志物。”循环。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ishibashi M, Nishida H, Okuda S et al.: "Localization of parathyroid glands in hemodialysis patients using Tc-99m sestamibi imaging.."Nephron. 78. 48-53 (1998)
Ishibashi M、Nishida H、Okuda S 等人:“使用 Tc-99m sestamibi 成像对血液透析患者的甲状旁腺进行定位。”肾单位。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Higashi H, Okuda S, Tamaki K et al.: "The effects of a high salt diet on gene expression of Na+/H+ exchanger and growth in 5/6-nephrectomized rats."Nephrology. 4. 187-193 (1998)
Higashi H、Okuda S、Tamaki K 等人:“高盐饮食对 Na /H 交换器基因表达和 5/6 肾切除大鼠生长的影响。”肾脏病学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 25 条
Missing link between metabolic syndrome and chronic kidney disease.?Role of asymmetric dimethylarginine-
-
批准号:22590903
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2010
-
负责人:OKUDA Seiya
-
依托单位:
ADMA metabolism and microvascular damage in chronic renal diseases
-
批准号:19590971
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2007
-
负责人:OKUDA Seiya
-
依托单位:
ROLE OF AND REGULATION OF GROWTH FACTOR TGF-β IN GLOMERULAR LESIONS
-
批准号:15590869
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2003
-
负责人:OKUDA Seiya
-
依托单位:
REGULATION OF TGF_ACTIVITY FOR ATTENUATION OF GLOMERULAR LESIONS
-
批准号:13671133
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:2001
-
负责人:OKUDA Seiya
-
依托单位:
REGULATION OF TGF-beta ACTIVITY FOR ATTENUATION OF GLOMERULAR LESIONS
-
批准号:08671289
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1996
-
负责人:OKUDA Seiya
-
依托单位:
THE PERSISTENT ACTIVATION MECHANISM OF TGF-b IN PROGRESSIVE GLOMERULAR DISEASES
-
批准号:06671143
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1994
-
负责人:OKUDA Seiya
-
依托单位:
国内基金
海外基金
登录
查看更多内容
新型全氟醚羧酸通过端粒缩短激活TGF-β/Smad 通路致儿童肾功能损伤的机制研究
-
批准号:ZCLQN26H2604
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:王言
-
依托单位:
表观遗传调节因子BRD4调控TGF-β1相关纤维化基因和炎症因子参与腹膜透析相关性腹膜纤维化
-
批准号:2026JJ81639
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘抗寒
-
依托单位:
LOX通过激活TGF-β/SMAD通路介导糖尿病足溃疡难愈及复发的机制研究
-
批准号:2026JJ82108
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谭亮
-
依托单位:
基于上皮-间充质可塑性特征构建胶质瘤预后模型及靶向特定蛋白PTGFRN促进TGF-β/Smad3信号的机制研究
-
批准号:JCZRLH202601800
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
独活寄生汤靶向调控TGF-β1/Smad信号通路介导间充质干细胞成软骨分化治疗KOA的作用机制研究
-
批准号:2026JJ80282
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:段建辉
-
依托单位:
针刀介导TGF-β/BMP信号通路调控软骨细胞分化及细胞外基质的合成以维持LDH局部微环境稳态的机制研究
-
批准号:2026JJ82498
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张立勇
-
依托单位:
黄精多糖通过TGF-β/SMAD信号通路抑制成纤维细胞活化治疗肺纤维化的机制研究与转化探索
-
批准号:JCZRLH202602010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
矾冰纳米乳靶控NLRP3介导IL-1β/TGF-β1轴清透“热气留滞”生肌不致成瘢的机制研究
-
批准号:2026JJ82090
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:魏源水
-
依托单位:
丁酸通过抑制HDAT6/TGF-β/Smad3介导的M2巨噬细胞极化改善慢性肾病肾纤维化
-
批准号:2026JJ82193
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:肖洁
-
依托单位:
TGF-β/PD-L1双特异性抗体重塑免疫-纤维化屏障协同CAR-T 细胞治疗肺癌的作用机制研究
-
批准号:JCZRLH202601008
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位: